Extended Stability of Ascorbic Acid in Pediatric TPN Admixtures: The Role of Storage Temperature and Emulsion

Rafał Chiczewski1, Żaneta Sobol1, Alicja Pacholska1

  • 1Department of Pharmaceutical Technology, Pomeranian Medical University in Szczecin, Rybacka 1, 70-204 Szczecin, Poland.

Pharmaceutics
|November 27, 2025
PubMed

Insights

Ascorbic acid (Vitamin C) in pediatric parenteral nutrition is stable refrigerated for 15 days. Room temperature exposure causes vitamin C loss, necessitating improved handling for home TPN programs.

Area of Science:

  • Parenteral nutrition
  • Nutritional biochemistry
  • Pharmaceutical stability

Background:

  • Pediatric total parenteral nutrition (TPN) requires stable vitamin formulations.
  • Assessing ascorbic acid stability under varied storage conditions is crucial for patient safety.
  • Hospital compounding and home administration present different stability challenges.

Purpose of the Study:

  • To evaluate the chemical and physical stability of ascorbic acid in pediatric TPN admixtures.
  • To compare stability under two distinct storage protocols simulating hospital and home settings.
  • To provide data for optimizing pediatric TPN formulation and handling.

Main Methods:

  • Quantified ascorbic acid degradation using validated high-performance liquid chromatography (HPLC).
  • Assessed physical stability via optical microscopy, dynamic light scattering (DLS), laser diffraction (LD), zeta potential, and pH.
  • Examined two storage protocols: 15-day refrigeration followed by 24h room temperature, and 24h supplementation then room temperature storage.

Main Results:

  • Ascorbic acid content remained above 90% in both protocols, with degradation increasing with time and temperature.
  • Physical stability was maintained; emulsion droplet sizes were <500 nm, with no phase separation.
  • Zeta potential confirmed kinetic stability (-20 to -40 mV), and pH remained within safe limits (5.8-6.2).

Conclusions:

  • Ascorbic acid is stable in pediatric TPN admixtures refrigerated for up to 15 days.
  • A 24-hour room temperature period leads to significant ascorbic acid loss, impacting home TPN.
  • Strict cold-chain management and appropriate packaging are vital for maintaining vitamin C integrity in pediatric TPN.

Related Concept Videos

Drug Product Stability01:16

Drug Product Stability

The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
218
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
232
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
168
Polyprotic Acids03:38

Polyprotic Acids

Acids are classified by the number of protons per molecule that they can give up in a reaction. Acids such as HCl, HNO3, and HCN that contain one ionizable hydrogen atom in each molecule are called monoprotic acids. Their reactions with water are:
31.7K
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
185
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
247